1-3 of 3
Yaxia Yuan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 7201: Targeting SLC38A1 non-conventional glutamine transporter in high risk MDS/AML

Free
Akansha Jalota, Anna Skwarska, Divij Verma, Kith Pradhan, Sovira Chaudhry, Gowri Poigaialwar, Vijaya Shukla, Yaxia Yuan, Elvin Wagenblast, Daohong Zhou, Stefano Tiziani, Amit Verma, Marina Konopleva
Journal: Cancer Research
Cancer Res (2025) 85 (8_Supplement_1): 7201.
https://doi.org/10.1158/1538-7445.AM2025-7201
Published: 21 April 2025
View articletitled, Abstract 7201: Targeting SLC38A1 non-conventional glutamine transporter in high risk MDS/AML
Journal Articles

Abstract PO3-26-10: Small molecule inhibitor of PELP1 exhibit cytotoxic effects on breast cancer cells by blocking ribosome biogenesis

Free
Xue Yang, Khaled Mohamed Nassar, Uday Pratap, Rahul Gopalam, Behnam Ebrahimi, Durga Meenakshi Panneerdoss, Xiaonan Li, Yaxia Yuan, Daohong Zhou, Gangadhara R. Sareddy, Rajeshwar R. Tekmal, Manjeet Rao, Suryavathi Viswanadhapalli, Ratna Vadlamudi
Journal: Cancer Research
Cancer Res (2024) 84 (9_Supplement): PO3-26-10.
https://doi.org/10.1158/1538-7445.SABCS23-PO3-26-10
Published: 02 May 2024
View articletitled, Abstract PO3-26-10: Small molecule inhibitor of PELP1 exhibit cytotoxic effects on breast cancer cells by blocking ribosome biogenesis
Journal Articles

A First-in-Class Inhibitor of ER Coregulator PELP1 Targets ER+ Breast Cancer

Available to Purchase
Kristin A. Altwegg, Suryavathi Viswanadhapalli, Monica Mann, Dimple Chakravarty, Samaya Krishnan, Zexuan Liu, Junhao Liu, Uday P. Pratap, Behnam Ebrahimi, John R. Sanchez, Xiaonan Li, Shihong Ma, Ben H. Park, Bindu Santhamma, Yidong Chen, Zhao Lai, Ganesh V. Raj, Yaxia Yuan, Daohong Zhou, Gangadhara R. Sareddy, Rajeshwar R. Tekmal, Stan McHardy, Tim H.-M. Huang, Manjeet K. Rao, Hariprasad Vankayalapati, Ratna K. Vadlamudi
Journal: Cancer Research
Cancer Res (2022) 82 (20): 3830–3844.
https://doi.org/10.1158/0008-5472.CAN-22-0698
Published: 17 October 2022
View articletitled, A First-in-Class Inhibitor of ER Coregulator PELP1 Targets ER+ Breast Cancer
Open the PDF for A First-in-Class Inhibitor of ER Coregulator PELP1 Targets ER+ Breast Cancer in another window
Includes: Supplementary data